Tamoxifen Completed Phase 2 Trials for mTor Protein / Neoplasms, Breast Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01298713Tamoxifen-RAD001 Versus Tamoxifen Alone in Patients With Anti-aromatase Resistant Breast Metastatic Cancer
NCT00229697Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa Study
NCT00543829German Preoperative Adriamycin Docetaxel Study
NCT00919399Exemestane (Aromasine) + Tamoxifen - Breast Neo-Adjuvant
NCT02970682SFX-01 in the Treatment and Evaluation of Metastatic Breast Cancer